- Home
- MCRB vs LGO Comparison
MCRB vs LGO Comparison
Compare MCRB & LGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- LGO
- Stock Information
- Founded
- MCRB 2010
- LGO 1988
- Country
- MCRB United States
- LGO Canada
- Employees
- MCRB N/A
- LGO N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- LGO
- Sector
- MCRB Health Care
- LGO
- Exchange
- MCRB Nasdaq
- LGO Nasdaq
- Market Cap
- MCRB 156.3M
- LGO 134.0M
- IPO Year
- MCRB 2015
- LGO 2007
- Fundamental
- Price
- MCRB $0.84
- LGO $1.78
- Analyst Decision
- MCRB Buy
- LGO Strong Buy
- Analyst Count
- MCRB 4
- LGO 1
- Target Price
- MCRB $5.63
- LGO $4.20
- AVG Volume (30 Days)
- MCRB 2.4M
- LGO 135.6K
- Earning Date
- MCRB 11-13-2024
- LGO 11-12-2024
- Dividend Yield
- MCRB N/A
- LGO N/A
- EPS Growth
- MCRB N/A
- LGO N/A
- EPS
- MCRB N/A
- LGO N/A
- Revenue
- MCRB $126,325,000.00
- LGO $144,822,000.00
- Revenue This Year
- MCRB N/A
- LGO N/A
- Revenue Next Year
- MCRB N/A
- LGO $37.73
- P/E Ratio
- MCRB N/A
- LGO N/A
- Revenue Growth
- MCRB 12856.41
- LGO N/A
- 52 Week Low
- MCRB $0.54
- LGO $1.38
- 52 Week High
- MCRB $2.05
- LGO $2.84
- Technical
- Relative Strength Index (RSI)
- MCRB 47.60
- LGO 43.41
- Support Level
- MCRB $0.80
- LGO $1.59
- Resistance Level
- MCRB $1.00
- LGO $1.77
- Average True Range (ATR)
- MCRB 0.06
- LGO 0.10
- MACD
- MCRB -0.01
- LGO 0.00
- Stochastic Oscillator
- MCRB 20.46
- LGO 43.18
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About LGO Largo Inc.
Largo Inc is committed to the production and supply of high-quality vanadium products. The Company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The Company has six operating segments: sales & trading wich generates key revenue, mine properties, corporate, exploration and evaluation properties, Largo Clean Energy, and Largo Physical Vanadium.